Primary pulmonary hypertension

Article Abstract:

Newer treatments are lengthening the lives of people with primary pulmonary hypertension. This condition is caused by high blood pressure in the pulmonary arteries. It affects 1 to 2 people per 1 million and some cases have a hereditary component. Elevation of blood pressure is caused by constriction of the arteries and the formation of blood clots that block blood flow. For this reason, the most effective treatments are vasodilators such as nitric oxide, epoprostenol, and adenosine as well as nifedipine and diltiazem. Anticoagulants and lung transplants have also led to improved survival rates.

Health aspects, Care and treatment, Lungs, Vasodilators, Vasodilator agents, Lung transplantation

---

Mars or Venus-is sex a risk factor for recurrent venous thromboembolism?

Article Abstract:

The identification of risk factors is essential for the management of a first episode of deep-vein thrombosis or pulmonary embolism. The studies on the risk factors revealed that the risk of recurrent venous thromboembolism is higher among men than women, because of the major risk of male sex.

Science & research, Sexual disorders, Research, Risk factors, Pulmonary embolism

---

Chronic thromboembolic pulmonary hypertension

Article Abstract:

The treatment of thromboembolic pulmonary hypertension is reviewed, focusing on surgical treatment. This condition is high blood pressure in the lungs caused by a blood clot that formed in the large veins of the legs and then traveled to the lungs.

Surgery

Similar abstracts:

• Abstracts: Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis. Defense factors of vaginal lactobacilli
• Abstracts: The optimal duration of anticoagulant therapy for venous thrombosis. Choosing a parenteral anticoagulant agent
• Abstracts: Self-fusion of the ALL1 gene: a new genetic mechanism for acute leukemia. Molecular basis of mature T-cell leukemia. (Special Communication)
• Abstracts: The management of thrombosis in the antiphospholipid-antibody syndrome. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
• Abstracts: Decreased erythropoietin response in patients with the anemia of cancer. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.